0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Behcet's Disease Epidemiology Forecast 2025-2034

  • PDF Icon

    Report

  • 150 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 6092307
Behcet’s disease (BD) is most commonly found in people living along the Silk Road, with the highest prevalence rate in Turkey (more than 1 in 1,000 people), compared to Japan, where it affects about 1 in 10,000 people. Men are more likely to have severe forms of the disease, while women are more likely to develop skin lumps similar to erythema nodosum. The disease is most frequently found in people between the ages of 20 and 40.

Behcet’s Disease Epidemiology Forecast Report Coverage

The “Behcet’s Disease Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of Behcet’s disease. It projects the future incidence and prevalence rates of Behcet’s disease across various populations. The study covers age and type as major determinants of the Behcet’s disease-affected population. The report highlights patterns in the prevalence of Behcet’s disease over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of Behcet’s disease in the 8 major markets.

Regions Covered

  • The United States
  • Germany
  • France
  • Italy
  • Spain
  • The United Kingdom
  • Japan
  • India

Behcet’s Disease: Disease Overview

Behcet's disease is defined as a rare, chronic, and multisystem inflammatory disorder. It is characterized by recurrent flare-ups and a wide range of symptoms. It is suggested that the disease is a result of an abnormal immune response, often triggered by genetic and environmental factors. Behcet’s disease affects multiple organ systems, including the skin, eyes, joints, blood vessels, and gastrointestinal tract. Painful mouth ulcers and genital ulcers are common symptoms of the disease.

Behcet’s Disease: Treatment Overview

The treatment approach of Behcet's disease varies depending on the severity and organs involved. Corticosteroids are commonly prescribed to control inflammation. Immunosuppressants such as azathioprine, cyclophosphamide, and methotrexate are prescribed to suppress the overactive immune response. Biologics like TNF inhibitors like infliximab or adalimumab are used to treat resistant or severe cases for reducing inflammation and preventing organ damage.

Epidemiology

The Behcet’s disease epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for Behcet’s disease by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for Behcet’s disease and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.
  • In Turkey, more than 1 in 1,000 people have Behcet's disease, while in Japan, it is about 1 in 10,000. It is reported that the disease is most common in populations along the Silk Road.
  • Behcet’s disease is most common in people aged 20-40 years, with the average age of onset being between 25 and 30 years. People who develop the disease before age 25 are more likely to experience eye problems and active symptoms.
  • Ocular disorders, such as posterior uveitis and retinal vasculitis, affect over 50% of people with Behcet's disease. Joint pain (arthralgia) or non-erosive, asymmetric arthritis are common in about 45% of cases and can be an early symptom.
  • The sex prevalence of Behcet's disease varies by country. In the Middle East, it is more common in males. The disease is slightly more common in females in countries like Germany, Japan, and Brazil. In the United States, females are more affected, with a 5:1 female-to-male ratio.

Country-wise Behcet’s Disease Epidemiology

The Behcet’s disease epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of Behcet’s disease varies significantly between countries due to differences in healthcare access, genetic predispositions, such as the presence of certain HLA-B51 gene variants, and environmental factors like climate or infections. The prevalence of Behcet’s disease, the types of symptoms, and the death rate vary by region and ethnicity. For instance, the disease is more prevalent in the Middle East and East Asia, but it is rare in North America.

Scope of the Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of Behcet’s disease based on several factors.
  • The Behcet’s Disease Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The report helps to identify the patient population, and the unmet needs of Behcet’s disease are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

  • What are the key findings of Behcet’s disease epidemiology in the 8 major markets?
  • What will be the total number of patients with Behcet’s disease across the 8 major markets during the forecast period?
  • What was the country-wise prevalence of Behcet’s disease in the 8 major markets in the historical period?
  • Which country will have the highest number of Behcet’s disease patients during the forecast period of 2025-2034?
  • Which key factors would influence the shift in the patient population of Behcet’s disease during the forecast period of 2025-2034?
  • What are the currently available treatments for Behcet’s disease?
  • What are the disease risks, signs, symptoms, and unmet needs of Behcet’s disease?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Introduction
1.2 Objectives of the Study
1.3 Research Methodology and Assumptions
2 Executive Summary
3 Behcet’s Disease Market Overview - 8 MM
3.1 Behcet’s Disease Market Historical Value (2018-2024)
3.2 Behcet’s Disease Market Forecast Value (2025-2034)
4 Behcet’s Disease Epidemiology Overview - 8 MM
4.1 Behcet’s Disease Epidemiology Scenario (2018-2024)
4.2 Behcet’s Disease Epidemiology Forecast
5 Disease Overview
5.1 Signs and Symptoms
5.2 Causes
5.3 Risk Factors
5.4 Guidelines and Stages
5.5 Pathophysiology
5.6 Screening and Diagnosis
6 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
7 Epidemiology Scenario and Forecast - 8 MM
7.1 Key Findings
7.2 Assumptions and Rationale
7.3 Behcet’s Disease Epidemiology Scenario in 8MM (2018-2034)
8 Epidemiology Scenario and Forecast: United States
8.1 Behcet’s Disease Epidemiology Scenario and Forecast in The United States (2018-2034)
9 Epidemiology Scenario and Forecast: United Kingdom
9.1 Behcet’s Disease Epidemiology Scenario and Forecast in United Kingdom (2018-2034)
10 Epidemiology Scenario and Forecast: Germany
10.1 Behcet’s Disease Epidemiology Scenario and Forecast in Germany (2018-2034)
11 Epidemiology Scenario and Forecast: France
11.1 Behcet’s Disease Epidemiology Scenario and Forecast in France
12 Epidemiology Scenario and Forecast: Italy
12.1 Behcet’s Disease Epidemiology Scenario and Forecast in Italy (2018-2034)
13 Epidemiology Scenario and Forecast: Spain
13.1 Behcet’s Disease Epidemiology Scenario and Forecast in Spain (2018-2034)
14 Epidemiology Scenario and Forecast: Japan
14.1 Behcet’s Disease Epidemiology Scenario and Forecast in Japan (2018-2034)
15 Epidemiology Scenario and Forecast: India
15.1 Behcet’s Disease Epidemiology Scenario and Forecast in India (2018-2034)
16 Patient Journey17 Treatment Challenges and Unmet Needs18 Key Opinion Leaders (KOL) Insights